Background. Vitamin D deficiency is prevalent in all the world countries. Recent studies show the correlation between vitamin D deficiency and musculoskeletal disorders. The purpose of this study is to examine vitamin D deficiency and insufficiency prevalence in patients of various ages, who have musculoskeletal disorders, and to reveal the influence of seasonal factors on these conditions. Materials and methods. 3460 patients of the Ukrainian scientific Medical Center of Osteoporosis Problems, aged 1 to 92 years, who were referred by other specialists to the center for bone state evaluation, were examined. A majority of the patients presented with osteoporosis and its complications, spinal osteochondrosis, knee and hip osteoarthritis (mean age -52.90 ± 21.10 years). Most of the patients were women (83.5 %). 25(ОН)D and parathyroid hormone analyses were performed by means of electrochemiluminescent method (Elecsys 2010 analyzer, Roche Diagnostics, Germany) and cobas test-systems. statistica 6.0 software package (Copyright statsoft, Inc., 1984 was also used. Results. Among the patients with musculoskeletal pathology, the highest 25(ОН)D level was noted in the age group of 1-9 years and the lowest -in the age group of 80 and over. 
Introduction
Vitamin D deficiency is prevalent in all countries around the world [1] [2] [3] . According to the recent evaluations, in the US, Canada and Europe from 20 to 100 % of elderly men and women who are private home residents, rather than nursing home residents, have a vitamin D deficiency. Risk of a vitamin D deficiency and insufficiency is equally high among the children and adults of young and middle age all over the world [4] .
Vitamin D is known as a fat-soluble vitamin, which promotes an effective absorption of dietary calcium and phosphorus, and as such, has vital importance for growth and bone mineralization. Vitamin D is synthesized in the human skin under the influence of solar ultraviolet radiation and is the major source of vitamin D for most children and adults [5, 6] . Skeletal disorders associated with vitamin D deficiency include rickets with associated bone deformities, osteoporosis and its complications and non-specific pain syndromes associated with osteomalacia [5] . Studies show the presence of vitamin D receptors in skeletal muscular nuclei, signifying vitamin D's connection with skeletal muscles function [7] . A study by M. Çidem et al. involving 14 925 patients aged 20-99 years with bone and muscular disorders observed vitamin D deficiency in 73.9 % of them [8] . Serum levels of 25(ОН)D were affected by season, age and sex. Note: here and in the tables 2-6: data are presented as М ± SD, where M -mean values, SD -standard deviation. Older people (60 and older) 1616 69.7 ± 6.9
Figure 1. Patients' distribution as to 25(ОН)D level
Vitamin D deficiency is also associated with cardiovascular diseases, diabetes mellitus, cancer, infections, autoimmune diseases [5, [9] [10] [11] [12] . In the European League Against Rheumatism (EULAR)-initiated study, 625 patients with rheumatoid arthritis (mean age -55 ± 11 years) recruited from 13 European countries were found to have a significantly lower mean 25(ОН)D serum level, amounting to 17.6 ± 9.8 ng/ml in winter months [13] .
Our previously conducted studies revealed a great number of Ukrainians suffering from vitamin D deficiency and insufficiency, equally affected by age, sex, body mass index, region of residence and season [14] [15] [16] [17] [18] .
The purpose of this study is to examine vitamin D deficiency and insufficiency prevalence in patients of various ages who have bone and muscular disorders, and to reveal the influence of seasonal factors on these conditions.
Materials and methods
3460 patients of the Ukrainian Scientific-Medical Center of Osteoporosis Problems, aged 1 to 92 years, who were referred by other specialists to the Center for a musculoskeletal evaluation. A majority of the patients presented with osteoporosis and its complications, spinal osteochondrosis and, knee and hip osteoarthritis (mean age -52.9 ± 21.1 years). Most of the patients were women (83.5 %), their mean age being 55.6 ± 19.4 years, while the men's mean age was 38.6 ± 17.3 years (р < 0.001).
Patients' distribution as to age and sex is shown in table 1.
Patients were further divided into three age groups: children (1-18 years), adults (19-59 years), elderly people (60 years and older) (table 2).
All of the subjects were evaluated as to the total level of 25(ОН)D (25(ОН)D total) and parathyroid hormone (PTH) in serum. 25(ОН)D total represents dietary and sun induced cutaneous vitamin D and is a measure of a person's vitamin D status [5] .
25(ОН)D and PTH analyses were performed by means of electrochemiluminescent method (Elecsys 2010 analyzer, Roche Diagnostics, Germany) and cobas testsystems. This method is, to date, considered the most sensitive, and is able to measure the studied substance concentration on a broad scope and with a high precision.
Vitamin D status was evaluated according to the latest classification [7] , vitamin D deficiency when serum levels of 25(ОН)D are lower than 20 ng/ml, vitamin D insufficiency when serum levels of 25(ОН)D are between 20 and 30 ng/ml. Serum levels of 25(ОН)D within the range of 31-100 ng/ml are considered normal. Levels above 150 ng/ml are considered to be potentially toxic.
Statistical analysis was performed by means of a descriptive statistics, Student criteria for unbound variables and one-way ANOVA dispersion analysis. Statistica 6.0 software package (Copyright StatSoft, Inc. 1984 was also applied.
Results

Age and sex related to 25(ОН)D levels in patients with musculoskeletal pathology
Histogram of patients' 25(OH)D levels is presented in fig. 1 .
Analysis of 25(ОН)D concentration in all the age groups (table 3) showed the highest levels in the age group of 1-9 years (30.6 ± 15.1 ng/ml), while the lowest levels were is found in the age group of 80 and over (20.4 ± 11.4 ng/ml). Mean level of the 25(ОН)D was 26.2 ± 11.9 ng/ml. According to one-way ANOVA analysis, the age significantly influenced 25(ОН)D values (F = 11,7; p < 0,000001).
We didn't find any significant difference in 25(ОН)D levels in children (boys (n = 165) -26.3 ± 14.3 ng/ml Передова стаття / Lead Article Notes: n -number of patients; r -correlation coefficient; t -Student criterion. and girls (n = 222) -27.2 ± 13.7 ng/ml, p = 0,54); in adults (men (n = 272) -25.9 ± 12.5 ng/ml and women (n = 1185) -26.0 ± 11.6 ng/ml, p = 0.87); in the elderly people (men (n = 134) -24.2 ± 12.0 ng/ml and women (n = 1482) -24.1 ± 11.6 ng/ml, p = 0.98).
We found that the prevalence of deficiency and insufficiency in patients with musculoskeletal complaints was 37.3 and 30.6 % respectively ( fig. 2 ).
34.8 % of children, 36.8 % of adults and 39.2 % of the elderly people were found to be vitamin D deficient and an additional 27.1 % of children, 31.0 % of adults and 31.1 % of the elderly people were vitamin D insufficient. Only 38.0 % (children), 33.2 % (adults), 29.6 % (elderly people) were vitamin D sufficient.
25(ОН)D level and its relation to age in patients with musculoskeletal disorders
Correlation and regression analyses of relation between 25(ОН)D levels and age are shown in fig. 3 and table 4.
The highest correlation coefficient between the 25(ОН)D levels and age was observed in children (r = -0.34; p < 0.001). Vitamin D status diminished with advancing age. The group of adults (r = 0.09; p < 0.001) and elderly people (r = -0.12; p < 0.001) had different vectors for 25(ОН)D levels changing with age; diminishing in the elderly, but slightly increasing in the younger adults.
Influence of age and the month of the year on 25(ОН)D levels of patients with musculoskeletal pathology
One-way ANOVA dispersion analysis revealed a significant influence on 25(ОН)D levels (F = 7.49: p < 0.001). The highest levels were observed in the months of August (28.6 ± 11.4 ng/ml) and September (28.6 ± 11.6 ng/ml) and the lowest in the months of February (23.1 ± 11.6 ng/ml) and March (23.4 ± ± 11.3 ng/ml) ( fig. 4) .
The age of some of the patients had a significant influence on the seasonal variation in 25 There was no significant influence on the seasonal variation in 25(OH)D levels in children up to 9 years and patients of 70 years and older.
Children had the lowest 25(ОН)D levels in February (20.8 ± 10.9 ng/ml), and the highest in August (35.7 ± 11.1 ng/ml); adults had the lowest 25(ОН)D levels in February (23.5 ± 12.0 ng/ml) and March (23.1 ± 10.4 ng/ml), and the highest in August (30.4 ± 10.8 ng/ml) and September (29.9 ± 11.1 ng/ml); elderly patients had the lowest 25(ОН)D levels in February (23.1 ± 11.3 ng/ml) and March (23.3 ± 11.0 ng/ml) and the highest in September (26.7 ± 11.1 ng/ml) ( fig. 5 ). 
Age and seasonal influence on 25(ОН)D level of patients with musculoskeletal pathology
Discussion
Vitamin D deficiency and insufficiency on chronic disease progression is a topical issue for scientists and medical practitioners around the world. The number of publications on the topic is ever increasing, as well as the number of international guidelines on vitamin D deficiency and insufficiency diagnostics, prophylaxis and treatment [19] [20] [21] [22] .
Before 2016, cross-sectional epidemiological studies performed in Ukraine [1, [15] [16] [17] showed a high incidence of vitamin D deficiency and insufficiency among the local population (90-95 %). We've also used several international studies for reference and comparison, among them MORE (International Multiple Outcomes of Raloxifene Evaluation Study) held in 25 countries in women older than 65 years who had osteoporosis [23] . In line with the MORE study we observed a seasonal influence on 25(ОН)D levels. The mean level of 25(ОН)D was 55.2 nmol/l (22.1 ng/ml) and higher than in our previous study of female patients [1, 14] . However the 25(ОН)D levels were lower in the patients with musculoskeletal pathology (24.2 ng/ml for the patients 60 years and older vs. 22.1 ng/ml). All of the patients in the MORE study were taking calcium and vitamin D supplements before the laboratory serum analysis like most patients in our own study. Nevertheless, we didn't include similar patients into the cross-sectional epidemiological study.
The large-scale study of vitamin D deficiency (Survey in Europe on Nutrition and the Elderly: a Concerted Action (SENECA)) [24] examined blood samples taken exclusively during the winter months, and only in patients of over 65 years who didn't take any vitamin D supplements. The mean 25(ОН)D level in this study was 33 nmol/l (13.2 ng/ml) while in our patients ta king part in a cross-sectional epidemiological study it was 30.4 nmol/l which is similar to the European population. However, our patients with musculoskeletal disorders had a higher 25(ОН)D level (24.4 ng/ml in patients of over 60 years in winter months vs.13.2 ng/ml).
Our study on 25(ОН)D level is the first study in the Ukraine involving patients of the Ukrainian Center of Osteoporosis who had musculoskeletal disorders. These Our findings show that 68.0 % of patients with musculoskeletal disorders were vitamin D deficient or insufficient 30.6 % of which were deficient or insufficient. A Danish study involving patients with spinal osteochondrosis reported a similar incidents which 33 % were vitamin D deficient [25] .
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Similarly, our findings correspond to the ones by Panwar A. et al. In this study, patients with musculoskeletal disorders had significant vitamin D deficiency with prevalence varying from 50.8 to 53.6 % during the winter months with the mean 25(ОН)D level of 21.4 ± 13.2 ng/ml [26] .
An Egyptian study of patients with fibromyalgia revealed a significantly lower mean 25(ОН)D level (15.1 ± 6.1 ng/ml) compared to our data (25.2 ± ± 12.0 ng/ml) [27].
B. Heidari et al. examined patients with a non-specific skeletal pain and found that 63.4 % were vitamin D deficient [28] .
A large-scale study involving 14 925 patients 73.9 % with musculoskeletal disorders, aged 20-99 years were found to be vitamin D deficient [29] . The authors of this study emphasized the seasonal, age and sex influence on serum 25(ОН)D levels. In March, patients had the highest risk of vitamin D deficiency with the lowest serum 25(ОН)D levels. Our results show only age-and season-related influences, with 25(ОН)D's lowest levels for adults in February (23.5 ± 12.0 ng/ml) and March (23.1 ± 10.4 ng/ml), for the elderly people (60-92 years) in February (23.1 ± 12.1 ng/ml) and March (23.3 ± 11.0 ng/ml).
The COMORA study involving 1413 patients with rheumatoid arthritis from 15 countries showed a mean serum 25(ОН)D levels of 27.3 ± 15.1 ng/ml. 8.5 % were vitamin D deficient and 54.6 % were vitamin D insufficient. In this study, vitamin D status was defined according to the Group for Research and Information on Osteoporosis (GRIO), as normal when vitamin D levels ≥ 30 ng/ml, insufficient when 10 ng/ml ≤ vitamin D levels < 30 ng/ml, and deficient when ≤ 10 ng/ml. The low incidence of vitamin D deficiency in this study was due to the fact that they 43 % of the patients were documented to have received vitamin D supplementation. Common factors associated with vitamin D deficiency were age, body mass index and patients' level of education [10] . In the European League Against Rheumatism (EULAR)-initiated study, 625 patients with rheumatoid arthritis serum (mean age -55 ± 11 years) recruited from 13 European countries were found to have a significantly lower mean serum 25(ОН)D levels of 17.6 ± 9.8 ng/ml in the winter months [13] . Mean serum 25(ОН)D levels were higher in all the age groups in our study (24.2 ± 13.8 in children; 24.5 ± 11.6 in adults and 24.4 ± 11.9 in the elderly patients).
Several studies have evaluated the effect of age on vitamin D status. In France, 68.3 % of elderly subjects (mean age -82.0 ± 7.8 years) were vitamin D deficient and 24.1 % were insufficient [13] . 39.3 and 31.1 % of our patients over 60 years (mean age -69.7 ± 6.9 years) were vitamin D deficient and insufficient respectively. The lower incidence is likely due to many of these patients receiving vitamin D and calcium supplementation by their treating physician.
34.9 and 38 % of the children who were examined at the Ukrainian Scientific-Medical Center of Osteoporosis were vitamin D deficient or insufficient respectively. A Korean study of children with non-specific leg pains revealed that 51.4 % were vitamin D deficient and 37.9 % were insufficient. The mean 25(ОН)D level of the Ukrainian children was 26.8 ± 14.0 ng/ml, while in the Korean study it was 17.2 ± 5.5 ng/ml [8] . 245 perimenopausal womenresidents of China with systemic osteoporosis had an extremely low 25(ОН)D levels of 14.4 ± 6.6 ng/ml which was significantly lower than in our study [30] .
Despite the combined calcium and vitamin D supplementation taken by most patients with a musculoskeletal pathology, only 37.9 % of children, 33.2 % of adults and 29.6 % of the elderly people had normal levels of 25(ОН)D and thus required additional vitamin D prescriptions (Guidelines for the Central and Eastern Europe).
Conclusions
The study allowed us to draw the following conclusions:
1. Among the patients with musculoskeletal pathology, the highest 25(ОН)D level was noted in the age group of 1-9 years (30,6 ± 15,1 ng/ml) and the lowest -in the age group of 80 and over (20.4 ± 11.4 3. Month of blood-sampling had a significant influence on 25(ОН)D level values (F = 7.49; p < 0,0000001). The highest 25(ОН)D levels were observed in August (28.6 ± 11.4 ng/ml) and September (28.6 ± 11.6 ng/ml), the lowest -in February (23.1 ± 11.6 ng/ml) and March (23.4 ± 11.3 ng/ml).
4. Children had the lowest 25(ОН)D level in February (20.8 ± 10.9 ng/ml), and the highest in August (35.7 ± ± 11.1 ng/ml); adults had the lowest in February (23.5 ± ± 12.0 ng/ml) and in March (23.1 ± 10.4 ng/ml), and the highest in August (30.4 ± 10.8 ng/ml) and September (29.9 ± 11.1 ng/ml); elderly people had the lowest 25(ОН)D levels in February (23.1 ± 11.3 ng/ml) and in March (23.3 ± 11.0 ng/ml), and the highest in September (26.7 ± ± 11.1 ng/ml).
5. The highest significant differences in 25(ОН)D levels during the summer vs. winter months were observed in the age groups of 10-19 years (18.2 %), 40-49 years (17.3 %), 30-39 years (16.2 %) and 1-9 years (16.1 %). There were no significant seasonal differences observed in the elderly patients (60 years and older) with musculoskeletal pathology.
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